These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27288544)

  • 21. Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics.
    Liwei L; He L; Yibo D; Luyang Z; Zhihui S; Nan K; Danhua S; Junzhu W; Zhiqi W; Jianliu W
    World J Surg Oncol; 2023 Oct; 21(1):332. PubMed ID: 37865800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
    An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
    Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
    Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
    Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of differential gene expression in different stage human endometrial cancer].
    Wan XP; Cai B; Liu L; Xi XW; Yang YX
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):38-42. PubMed ID: 16635327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma.
    Kamal M; Burmeister C; Zhang Z; Munkarah A; Elshaikh MA
    Anticancer Res; 2015 Jul; 35(7):4053-7. PubMed ID: 26124354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
    Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular classification of human endometrial cancer based on gene expression profiles from specialized microarrays.
    Yao Y; Chen Y; Wang Y; Li X; Wang J; Shen D; Wei L
    Int J Gynaecol Obstet; 2010 Aug; 110(2):125-9. PubMed ID: 20471643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy.
    Bakhsh S; Kinloch M; Hoang LN; Soslow RA; Köbel M; Lee CH; McAlpine JN; McConechy MK; Gilks CB
    Histopathology; 2016 May; 68(6):916-24. PubMed ID: 26416160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
    Bregar A; Deshpande A; Grange C; Zi T; Stall J; Hirsch H; Reeves J; Sathyanarayanan S; Growdon WB; Rueda BR
    Gynecol Oncol; 2017 Jun; 145(3):446-452. PubMed ID: 28347512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.
    Moreno-Bueno G; Sánchez-Estévez C; Cassia R; Rodríguez-Perales S; Díaz-Uriarte R; Domínguez O; Hardisson D; Andujar M; Prat J; Matias-Guiu X; Cigudosa JC; Palacios J
    Cancer Res; 2003 Sep; 63(18):5697-702. PubMed ID: 14522886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.
    An HJ; Lee YH; Cho NH; Shim JY; Kim JY; Lee C; Kim SJ
    Histopathology; 2002 Nov; 41(5):437-45. PubMed ID: 12405911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy.
    Ravegnini G; Gorini F; Coada CA; De Leo A; de Biase D; Di Costanzo S; De Crescenzo E; Coschina E; Monesmith S; Bernante P; Garelli S; Balsamo F; Hrelia P; De Iaco P; Angelini S; Perrone AM
    Cancer Sci; 2024 Mar; 115(3):883-893. PubMed ID: 38196275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.
    Billingsley CC; Cansino C; O'Malley DM; Cohn DE; Fowler JM; Copeland LJ; Backes FJ; Salani R
    Gynecol Oncol; 2016 Mar; 140(3):405-8. PubMed ID: 26801939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer.
    Cummings M; Massey KA; Mappa G; Wilkinson N; Hutson R; Munot S; Saidi S; Nugent D; Broadhead T; Wright AI; Barber S; Nicolaou A; Orsi NM
    J Pathol; 2019 Jan; 247(1):21-34. PubMed ID: 30168128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
    Ashley CW; Da Cruz Paula A; Kumar R; Mandelker D; Pei X; Riaz N; Reis-Filho JS; Weigelt B
    Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
    Travaglino A; Raffone A; Gencarelli A; Mollo A; Guida M; Insabato L; Santoro A; Zannoni GF; Zullo F
    Pathol Oncol Res; 2020 Oct; 26(4):2067-2073. PubMed ID: 32472441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.
    Meng B; Hoang LN; McIntyre JB; Duggan MA; Nelson GS; Lee CH; Köbel M
    Gynecol Oncol; 2014 Jul; 134(1):15-9. PubMed ID: 24844595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.